Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185393
Status:
COMPLETED
Last Update Posted:
2008-12-01
First Post:
2005-09-12
Brief Title:
Treatment With 90Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma Stage III or IV Having Achieved a Partial or Complete Remission After First Line Chemotherapy
Sponsor:
Organization:
Bayer